Exabis Library
Welcome to the e-CCO Library!
P623: Quality of life as predictor of biological levels decay in inflammatory bowel diseases
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P623: The effectiveness and tolerability of Crohn’s disease exclusion diet in adult Crohn’s disease patients: a retrospective study
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P623: The impact of SARS-CoV-2 outbreak on the treatment adherence and clinical outcome of patients with inflammatory bowel disease treated with biological agents.
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P623: Therapeutic preferences and outcomes in newly diagnosed patient with inflammatory bowel diseases in the biological era in Hungary. A nationwide study based on the National Health Insurance Fund database
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P624 Maintenance of remission after treatment with Exclusive Enteral Nutrition and Azathioprine in paediatric patients with Crohn’s disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P624: A higher prevalence of human papillomavirus in patients with perianal fistulizing Crohn's disease compared to patients with anorectal fistula without Crohn's disease.
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P624: Chromoendoscopy and narrow band imaging versus conventional white light endoscopy for detection of neoplasia in ulcerative colitis – a systematic review and meta-analysis
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P624: Factors that may influence the development of anti-drug antibodies to adalimumab
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P624: Investigating the symptom burden among European patients with moderate-to-severe Crohn's disease using a real-world survey
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P624: Long-term effectiveness of anti-TNF therapy in pediatric-onset inflammatory bowel diseases: a population-based study
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P624: Vedolizumab can induce clinical remission in patients with chronic antibiotic-refractory pouchitis: A retrospective single-centre experience
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P625 Kinetics and outcomes of transmural healing in patients with Crohn’s disease treated with anti-TNF therapy
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P625: A prospective study to assess the effectiveness of tacrolimus therapy in ulcerative colitis
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P625: Characteristics of SARS-CoV-2 infection in IBD patients in the second and third wave compared with the first wave and with the data of general population
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P625: Head-to-head comparison of three stool calprotectin tests for home use
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P625: Predictors of pancreatitis among patients with inflammatory bowel disease (IBD) treated with vedolizumab (VDZ): Observation from a large global safety database
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P625: Randomized controlled trial on the effect of megaboluses of intravenous corticosteroids added to oral corticosteroids in the treatment of moderately active ulcerative colitis
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P625: Ustekinumab use in Crohn's disease: effectiveness of dose escalation
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P626 Patients with IBD seek extra supportive care: insights from Israeli social media networks
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P626: Anti-TNF monotherapy is associated with an adverse clinical outcome in female Inflammatory Bowel Disease patients who stop Anti-TNF treatment during the third trimester of pregnancy.
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM